Compare ELDN & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELDN | HYPR |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.6M | 107.9M |
| IPO Year | 2014 | 2021 |
| Metric | ELDN | HYPR |
|---|---|---|
| Price | $2.69 | $1.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $8.50 | $1.28 |
| AVG Volume (30 Days) | ★ 900.4K | 293.1K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.27 | 9.68 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,890,000.00 |
| Revenue This Year | N/A | $5.96 |
| Revenue Next Year | N/A | $34.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.84 |
| 52 Week Low | $1.35 | $0.53 |
| 52 Week High | $4.60 | $2.22 |
| Indicator | ELDN | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 56.48 |
| Support Level | $2.48 | $1.04 |
| Resistance Level | $2.77 | $1.19 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 54.23 | 72.09 |
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.